Z. Garrett

发表

Speech and language therapy interventions for children with primary speech and language delay or disorder.

J. Law, Z. Garrett, C. Nye, 2003, The Cochrane database of systematic reviews.

Speech and Language Therapy: Its Potential Role in CAMHS.

J. Law, Z. Garrett, 2004, Child and adolescent mental health.

Randomised controlled trials for policy interventions: a review of reviews and meta-regression.

J Thomas, J Shepherd, I. White, 2010, Health technology assessment.

European collaboration on health technology assessment: looking backward and forward

Z. Garrett, C. Bélorgey, Alessandra Lo Scalzo, 2022, International Journal of Technology Assessment in Health Care.

Building a model of health technology assessment cooperation: lessons learned from EUnetHTA joint action 3

Z. Garrett, Iñaki Imaz-Iglesia, A. Willemsen, 2022, International Journal of Technology Assessment in Health Care.

EVIDENCE REQUIREMENTS FOR REIMBURSEMENT OF PHARMACEUTICALS ACROSS EUROPE

O. Oyebode, Z. Garrett, A. Cangini, 2015, International Journal of Technology Assessment in Health Care.

NICE DSU TECHNICAL SUPPORT DOCUMENT 11 : ALTERNATIVES TO EQ-5 D FOR GENERATING HEALTH STATE UTILITY

J. Cairns, J. Brazier, D. Rowen, 2012 .

The fourth edition of the European Network for Health Technology Assessment Forum: highlights and outcomes

D. Lacombe, I. Saeterdal, Z. Garrett, 2020, International Journal of Technology Assessment in Health Care.

RCTs for policy interventions?: a review of reviews and meta-regression

I. White, S. Oliver, K. Oliver, 2008 .

The Evidence for Policy and Practice Information and Co- ordinating Centre (EPPI-Centre) links

Z. Garrett, Irene Krechowiecka, L. Marris, 2004 .

VP30 Research And Analysis Of European Health Technology Assessment Processes

Z. Garrett, J. Sus, 2017, International Journal of Technology Assessment in Health Care.

NICE guidance on trastuzumab for the treatment of HER2-positive metastatic gastric cancer.

Z. Garrett, Joanne Holden, A. Stevens, 2011, The Lancet. Oncology.

The efficacy of treatment for children with developmental speech and language delay/disorder: a meta-analysis.

James Law, Chad Nye, J. Law, 2004, Journal of speech, language, and hearing research : JSLHR.

Speech and language therapy interventions for children with primary speech and language delay or disorder (Cochrane Review)

James Law, Chad Nye, J. Law, 2003 .

NICE guidance on rituximab for first-line treatment of symptomatic stage III-IV follicular lymphoma in previously untreated patients.

F. Sutcliffe, Z. Garrett, A. Stevens, 2012, The Lancet. Oncology.

The impact on health-related quality of life of caregiving within the household for people with arthritis

Z. Garrett, 2016 .

Systematic reviews and their application to research in speech and language therapy: a response to T. R. Pring's 'Ask a silly question: two decades of troublesome trials' (2004).

Z. Garrett, James Thomas, 2006, International journal of language & communication disorders.

Secondary school size: a systematic review

D. Elbourne, Jim Taylor, A. West, 2004 .

Strategy training in language learning - A systematic review of available research

Robert Vanderplank, Xavière Hassan, G. Nye, 2005 .

Does secondary school size make a difference?: A systematic review

Anne West, Steve Bradley, Diana Elbourne, 2006 .

NICE guidance on denosumab for prevention of skeletal-related events in adults with bone metastases from solid tumours.

F. Sutcliffe, Z. Garrett, A. Stevens, 2012, The Lancet. Oncology.